Hexagon Nutrition Limited held a Q1 FY27 Earnings Conference Call on August 14, 2026. The event was an earnings call to discuss the company's Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

Management Participants:

  • Dr. Nikhil Kelkar – Joint Managing Director
  • Mr. Vikram Kelkar – Managing Director
  • Mr. Soman Jana – Chief Financial Officer

Financial Highlights Discussed:

  • Consolidated revenue from operations: INR104.3 crores (43.2% YoY growth from INR72.9 crores in Q1 FY26)
  • EBITDA: INR11.8 crores (17.3% YoY growth from INR10.1 crores)
  • Profit after-tax: INR8.1 crore (25.1% YoY growth from INR6.5 crores)
  • EBITDA margin: 11.3% (vs 13.8% in Q1 FY26)
  • PAT margin: approximately 7.7%
  • Gross profit: INR45.8 crore (34.1% YoY growth from INR34.1 crores)

Business Segment Performance:

  • Branded business: 28% of total revenue, grew 28% YoY
  • Premix business: 62% of total revenue, grew 55% YoY
  • Therapeutic (ESG) segment: 10% of total revenue, grew 42% YoY

Operational Updates:

  • Current order book: INR100 crores (70-75% premix and ESG, rest branded segment)
  • Capacity utilization: 47% overall (Nashik: 55-60%, Chennai: 25-30%, Tuticorin: 35-40%)
  • Export contribution: Less than 20% from West Asia, diversified across 70+ countries
  • Geographic expansion focus: Central Asia, Africa, Europe, and North America

Guidance and Outlook:

  • FY27 revenue growth guidance: 20-25%
  • Branded business target: 35% of total revenue in next couple of years
  • Capex plan: INR25-30 crores for Nashik factory redevelopment over 1-1.5 years
  • Margin improvement expected through price increases (10-15% MRP hike implemented)

Strategic Initiatives:

  • Expansion into Tier 2 and Tier 3 cities with increased field force
  • Strengthening e-commerce presence across Amazon, Flipkart, e-pharmacies
  • Focus on newer therapy areas: fertility nutrition, women's health (Nutrone Women)
  • R&D investment in innovative formulations and nutrition solutions

Additional Notes Section

The transcript of the earnings conference call was disseminated on the company's website at www.hexagonnutrition.com. The document represents a regulatory filing under Regulation 30 of SEBI Listing Regulations. The announcement contained detailed financial data from the quarterly results. The company indicated during the call that they are taking measures to mitigate gross margin pressure through price increases and operational efficiencies.